Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Curr Opin Endocr Metab Res. 2018 Feb 5;2:29–33. doi: 10.1016/j.coemr.2018.01.007

Figure 2. Inhibition of TSH- and IGF1-stimulated HA secretion by TSHR antagonist C1 and IGF-1R antagonist linsitinib.

Figure 2

Reprinted from (13). The TSHR inhibitor C1 fully inhibited TSH and partially inhibited IGF1 and TSH+IGF1 stimulation of HA secretion. The IGF1R inhibitor fully inhibited IGF1 and partially inhibited TSH and TSH+IGF1 stimulation. *P<0.03, **P<0.001